SGMO Financial Facts

Loss from operations: -16.68M
Collaboration agreements: 3.71M
See Full Income Statement

Total stockholders' equity: 179.41M
Interest receivable: 402K
See Full Balance Sheet

Sangamo Biosciences Inc. (SGMO) Earnings

  |   Expand Research on SGMO
Next EPS Date 8/5/16 *Est. EPS Growth Rate -187.5% *Last Qtr.
Average EPS % Beat Rate +6.5% Revenue Growth Rate -70.8% *Last Qtr.
Average % Move 1-Wk after EPS -4.9% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/2/16 Q116 -$0.23-$0.24 +$0.01$3.94M$5.49M = Details
2/9/16 Q415 -$0.20-$0.21 +$0.01$9.1M$9.86M = Details
10/28/15 Q315 -$0.13-$0.25 +$0.12$8.6M$13.09M = Details
8/5/15 Q215 -$0.17-$0.13 -$0.04$8.4M$14.72M = Details
4/22/15 Q115 -$0.08-$0.14 +$0.06$13.5M$12.5M = Details
2/10/15 Q414 -$0.06-$0.09 +$0.03$14.95M$14.5M = Details
10/22/14 Q314 -$0.11-$0.14 +$0.03$12.4M$8.27M = Details
7/23/14 Q214 -$0.10-$0.14 +$0.04$10.4M$7.84M = Details